Sentences with phrase «pharmaceutical market in»

By 2010, all pharmaceuticals marketed in Sweden are supposed to be assessed, excluding those unlikely to have an environmental impact, such as vitamins.

Not exact matches

Areas where positions are available: The world's sixth - largest pharmaceutical company has a number of open roles with sales and marketing, scientific positions, and jobs in its manufacturing and supply chain areas.

You measure a country's ability to innovate using myriad factors, including registered trademarks, articles published in scientific journals and the size of its export market in fields like electronics or pharmaceuticals.

The biggest company in Canada by market cap on the TSX — an admittedly capricious metric — is now Valeant Pharmaceuticals, which surpassed the Royal Bank of Canada this week.

State Attorney General Andy Beshear is bringing suit against Endo Pharmaceuticals, which makes the opioid Opana ER, for alleged fraudulent and deceptive marketing practices which have contributed to a rising tide of painkiller - related deaths in Kentucky.

Health Canada said that four companies have authorization to sell epinephrine auto - injectors — Kaleo Pharma, Taro Pharmaceutical Industries Ltd, Valeant Pharmaceuticals International Inc and Lincoln Medical Ltd — but none are currently marketing them in the country.

Then the continuing wave of mergers and acquisitions created market - dominating behemoths of seemingly impossible size, in industries ranging from telecommunications and financial services to pharmaceuticals and the media.

Given rising competition in the generics space, Teva could also use the additional size to gain back market share from Indian manufacturers such as Sun Pharmaceuticals.

According to the GAO report, 71 percent of all generic injectable cancer drugs sold in 2008 were produced by just three manufacturers, while 91 percent of the market share of injectable nutrients and supplements was held by just three pharmaceutical firms.

Generic pharmaceutical companies operate in a more competitive market with enormous price pressures.

Adding Actelion's portfolio to our already strong Janssen Pharmaceuticals business is a unique opportunity for us to expand our portfolio with leading, differentiated in - market medicines and promising late - stage products.

Contrary to the consumer's ideal in which bare - knuckled rivals cut prices to grab market share, competitors in branded pharmaceuticals often drive each other's prices higher.

While this underlines the risks of investing in pre-revenue companies, the good news is biotech is strictly regulated by national pharmaceutical regulatory authorities in the US, Europe and China, which is one reason that biotech made sense for our market.

Amgen's 22 % ROIC is among the best in the large - cap pharmaceutical industry, and it's undervalued against both its peers and the broader market.

Local companies Insight Pharmaceuticals and Clarion Brands were growing rapidly in the over-the-counter consumer products space — so much so that the brands were in the market for a technology advisor.

MDMA was originally patented by pharmaceutical giant Merck in 1912, but it was never marketed and the patent lapsed.

Deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can sometimes be illegal and therefore can be challenged in court, the Supreme Court said Monday...

Major pharmaceuticals firms also engage in research and development, but tend to focus more on manufacturing and marketing an existing portfolio of drugs than the typical biotech firm.

The pharmaceutical industry is typically reluctant to talk about U.S. drug prices, generally the highest in the world due to a combination of market fragmentation and free market policies.

Valeant Pharmaceuticals International, Inc. (NYSE / TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorder, eye health, neurology and branded generics.

Dr. Hopfield is a former Partner of McKinsey & Company in its global pharmaceuticals and medical devices practice, where she led work in strategy, R&D management, and marketing across pharmaceutical, biotech, medical device and consumer industries.

In May generic drug company Actavis Inc. agreed to buy Warner Chilcott PLC for $ 8.5 billion in stock, creating the third - biggest specialty pharmaceutical company in the U.S. markeIn May generic drug company Actavis Inc. agreed to buy Warner Chilcott PLC for $ 8.5 billion in stock, creating the third - biggest specialty pharmaceutical company in the U.S. markein stock, creating the third - biggest specialty pharmaceutical company in the U.S. markein the U.S. market.

With several drugs currently acting as significant drivers of growth, J&J's pharmaceutical segment looks well placed even as the company strives to maintain its market share in consumer healthcare and medical devices.

Interviews with former Sprout employees, analysts, investors and doctors who helped bring the drug to market suggest how a series of missteps after the deal, along with turbulence from aggressive accounting practices, unusual business relationships and big egos, derailed one of the most intriguing new pharmaceuticals in a generation.

I remember one day about 13 years ago, when I was a daytrader, I immediately noticed relative strength in the pharmaceutical sector ($ DRG) shortly after the market opened.

Sally Evans, a 61 - year - old pharmaceutical - industry sales analyst in the Chicago area, recalls her friends «bailing from the market,» even as she increased her retirement - account contributions and invested more aggressively in stocks.

We see attractive dividend - growth opportunities in global pharmaceuticals, international telecom, emerging market (EM) infrastructure and selected information technology companies.

In the meantime, established pharmaceutical companies can replicate the product awaiting review and then file a special 180 - day market exclusivity patent, which essentially steals the product and creates a temporary monopoly.

Weber, who became Takeda's first non-Japanese CEO in 2015, has said publicly it was looking for acquisitions to reduce its exposure to a mature Japanese pharmaceutical market.

Before any company can make and market even a generic pharmaceutical drug in the United States, it must be granted a special authorization by the FDA.

Capital Markets M&A Pharmaceuticals In what could become Israel's biggest cross-border M&A deal ever, Teva Pharmaceutical Industries made an unsolicited $ 40 billion offer to acquire Mylan, a Pennsylvania - based drugmaker registered in the Netherlands with operational headquarters in the UIn what could become Israel's biggest cross-border M&A deal ever, Teva Pharmaceutical Industries made an unsolicited $ 40 billion offer to acquire Mylan, a Pennsylvania - based drugmaker registered in the Netherlands with operational headquarters in the Uin the Netherlands with operational headquarters in the Uin the UK.

Capital Markets Merger & Acquisitions: Biotech The slew of M&A deals in the pharmaceutical industry could leave some firms with a bad hangover.

AbbVie, the pharmaceutical unit of Abbott Laboratories, sold $ 14.7 billion worth of bonds in the largest offering in the US corporate debt market in more than three years.

In 1996, Purdue Pharmaceuticals brought to market OxyContin, an «extended release» version of the opioid oxycodone.

These early objections were swept aside, however, and emergency contraception products are now available worldwide, with a pharmaceutical company in the United States even providing «full - on, direct - to - consumer marketing».

The company has been working with companies in various segments of the market in Canada and the United States, and its goals include aligning with current product and consumer trends and offering top - quality food ingredients to the food, pharmaceuticals and nutraceutical industries.

«Retort foods and pharmaceuticals packaging are growing markets, for example for PET - based transparent deposition films, while high - barrier films are used in case - ready and modified atmosphere packaging.

They can look forward to market leaders in technology, covering the entire value chain in the core areas of food, pharmaceuticals, confectionery and baked goods, cosmetics, the retail trade, the automotive industry, milk and meat products, drinks and liquid food.

Food and Beverages are the largest sectors in the Italian packaging market, followed by Health & Beauty and Pharmaceuticals.

Alcohol Industry Bankrolls Fight Against Legal Pot in Battle of the Buzz: The fight against legalized pot is being heavily bankrolled by alcohol and pharmaceutical companies, terrified that they might lose market share...

It also produces machinery used in the pharmaceutical and chemical markets.

The design and manufacture of advanced injection molding and assembly systems are a growing influence in the medical device, drug delivery, and primary pharmaceutical packaging markets.

Rousselot is the world leader in the production and marketing of gelatine and collagen peptides to the food and pharmaceutical industries.

With the development of smarter packaging, this specialist for secondary packaging in the pharma / pharmaceutical and healthcare industry meets the needs of increased digitalisation on the e-health market and the growing interest in interactive packaging solutions.

The pharmaceuticals market was a major driver of growth for German packaging machinery specialist Bosch Packaging Technology in 2013.

Innophos is a leading international producer of performance - critical and nutritional specialty ingredients, with applications in food, beverage, pharmaceutical, oral care and industrial end markets.

The global packaging divider market is expected to grow at a CAGR of close to 6 % during 2017 - 2021 period, report projects; food and beverage accounted for close to 33 % of total market in 2016, while pharmaceuticals held 27 % market share and automotive took 18 %.

Best Label a privately - owned label manufacturer on the West Coast with facilities in Mexico and California, has purchased and installed the Epson SurePress L - 6034VW to expand its short - run label printing offerings for customers in several markets, including food, beverage, health, beauty, pharmaceutical, nutraceutical, sports, automotive, agricultural, and chemical manufacturing.

Constantia Flexibles (www.cflex.com), a world leading manufacturer of flexible packaging products and labels that supplies multinational corporations and local market leaders in the food, pet food, pharmaceuticals and beverage industries, has hired Dr. Ibon Odriozola as head of innovation, laminates for the company's pharma division.

The VIPColor VP485 color label printer is also perfect for the regionalization required for products sold within foreign markets and is particularly suited for gourmet food labels, beverage labels, sauce labels, food supplement labels, vitamin labels, pharmaceutical labels, nutraceutical labels, chemical labels, GHS labels, medical device labels, hardware labels, Do - It - Yourself in store labels, color picture shoe box labels and apparel price tags applications.